Clinical Trial Update: Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Cubicin (daptomycin) with vancomycin in complicated skin and skin structure infections in a home infusion setting; study terminated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infection

Drugs mentioned

• Cubicin (daptomycin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Complicated Skin or Skin Structure Infection | Phase 4 | Status: TERMINATED | Results posted: 2015-05-13